|
RAP2C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56192999999361E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.00329966556956E-10 |
| Normal-vs-Stage2 |
5.580000E-01 |
| Normal-vs-Stage3 |
7.570400E-02 |
| Normal-vs-Stage4 |
8.758700E-03 |
| Stage1-vs-Stage2 |
1.945990E-01 |
| Stage1-vs-Stage3 |
1.387980E-02 |
| Stage1-vs-Stage4 |
2.917000E-01 |
| Stage2-vs-Stage3 |
8.148800E-01 |
| Stage2-vs-Stage4 |
4.399800E-01 |
| Stage3-vs-Stage4 |
4.003200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.44830000506857E-09 |
| Normal-vs-AfricanAmerican |
6.759500E-03 |
| Normal-vs-Asian |
6.228000E-01 |
| Caucasian-vs-AfricanAmerican |
2.336600E-01 |
| Caucasian-vs-Asian |
3.388200E-02 |
| AfricanAmerican-vs-Asian |
4.607000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.81169976190654E-10 |
| Normal-vs-Female |
2.113800E-02 |
| Male-vs-Female |
1.394340E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.86542999999206E-05 |
| Normal-vs-Extreme_Weight |
2.27559970866764E-10 |
| Normal-vs-Obese |
1.280130E-02 |
| Normal-vs-Extreme_Obese |
7.963100E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.217800E-01 |
| Normal_Weight-vs-Obese |
2.236800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.609400E-01 |
| Extreme_Weight-vs-Obese |
4.513600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.180400E-01 |
| Obese-vs-Extreme_Obese |
2.128800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.071170E-01 |
| Normal-vs-Age(41-60Yrs) |
1.5059000000317E-06 |
| Normal-vs-Age(61-80Yrs) |
3.2825999995989E-07 |
| Normal-vs-Age(81-100Yrs) |
9.57259999999627E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.131800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.734100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.388300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.297900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.279030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.703000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.18990000000474E-06 |
| Normal-VS-Type2 PRCC |
1.754190E-04 |
| Normal-VS-KIRP CIMP |
2.788800E-01 |
| Normal-VS-Unclassified PRCC |
1.961930E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.014400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.135700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.511010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.361410E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.627400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.370600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63762999999539E-05 |
| Normal-vs-N1 |
1.074560E-01 |
| Normal-vs-N2 |
1.992560E-01 |
| N0-vs-N1 |
4.174200E-02 |
| N0-vs-N2 |
4.622600E-01 |
| N1-vs-N2 |
7.923600E-01 |
|
|
